Ethambutol
Ethambutol (EMB, E) is a medication primarily used to treat tuberculosis. It is usually given in combination with other tuberculosis medications, such as isoniazid, rifampicin and pyrazinamide. It may also be used to treat Mycobacterium avium complex, and Mycobacterium kansasii. It is taken by mouth.
Chemical structure of ethambutol (top) and photo of ethambutol crystals (bottom) | |
Clinical data | |
---|---|
Trade names | Myambutol, Etibi, Servambutol, others |
Other names | (2S,2’S)-2,2’-(Ethane-1,2-diyldiimino)dibutan-1-ol |
AHFS/Drugs.com | Monograph |
License data |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 20–30% |
Metabolism | liver |
Elimination half-life | 3–4 hours |
Identifiers | |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.737 |
Chemical and physical data | |
Formula | C10H24N2O2 |
Molar mass | 204.314 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
|
Common side effects include problems with vision, joint pain, nausea, headaches, and feeling tired. Other side effects include liver problems and allergic reactions. It is not recommended in people with optic neuritis, significant kidney problems, or under the age of five. Use during pregnancy or breastfeeding has not been found to cause harm. In the United States the FDA has raised concerns about eye issues in the baby if used during pregnancy. Ethambutol is believed to work by interfering with the bacteria's metabolism.
Ethambutol was discovered in 1961. It is on the World Health Organization's List of Essential Medicines and is available as a generic medication.